Innovation - Drugs and diagnostics

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue SUPPL. 1, 2007, Pages

  Finch, Roger ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Antimicrobials; Drug development; Education; Prescribing; Surveillance

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIAL INFECTION; DRUG UTILIZATION; HUMAN; RESEARCH; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG UTILIZATION; HUMANS; RESEARCH;

EID: 84877911547     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm165     Document Type: Article

References (17)

1. Report of the Select Committee on Science and Technology of the House of Lords 1998. Resistance to Antibiotics and Other Antimicrobial Agents. http://www.parliament.the-stationery-office.co.uk/ pa/ld199798/ldselect/ldsctech/081vii/st0701.htm (12 March 2007, date last accessed).
2. Cassell GH. ASM Task Force urges broad program on antimicrobial resistance. ASM News 1995; 61: 116-20.
3. World Health Organisation. World Health Report on Infectious Diseases 2000. Overcoming Antimicrobial Resistance. http://www.who.int/infectious-disease-report/2000/other_versions/index-rpt2000_text.html (14 February 2007, date last accessed).
4. The Copenhagen Recommendations. Report from the Invitational EU Conference on the Microbial Threat, Copenhagen Denmark, 9-10 September 1998. www.im.dk/publikationer/micro98/recommen.htm (14 February 2007, date last accessed).
5. The Microbial Threat. Progress Report on Antimicrobial Resistance. EU Conference, Visby, Sweden, 13-15 June 2001. http://www.sos.se/FULLTEXT/123/2001-123-68/summary.htm (14 February 2007, date last accessed).
6. The European Antimicrobial Resistance Surveillance System (EARSS). http://www.rivm.nl/earss (14 February 2007, date last accessed).
7. European Surveillance of Antimicrobial Consumption (ESAC). www.esac.ua.ac.be (14 February 2007, date last accessed).
8. Finch RG, Metlay JP, Davey PG et al. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 2004; 4: 44-53.
9. Fleming DM, Ross AM, Cross KW et al. The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing. Br J Gen Pract 2003; 53: 778-83.
10. Department of Health 2006. The Health Act 2006: Code of Practice for the Prevention and Control of Health Care Associated Infections. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4139336&chk=6oAPfi (14 February 2007, date last accessed).
11. Projan SJ. Why is big pharma getting out of antibacterial drug discovery? Curr Opin Microbiol 2003; 6: 1-4.
12. Controlling antibiotic resistance by rapid identification of susceptible target infections and pathogenic recognition. Proceedings of the 4th International Forum on Antibiotic Resistance (IFAR) Colloquium 2005. Clin Microbiol Infect 2006; 12 Suppl 9: 1-36.
13. Infectious Diseases Society of America 2004. Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates a Public Health Crisis Brews. http://www.idsociety.org/pa/IDSA_Paper4_final_web.pdf (14 February 2006, date last accessed).
14. Talbot GH, Bradley J, Edwards JE et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006; 42: 657-68.
15. Norrby SR, Nord CE, Finch RG. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 2005; 5: 115-9.
16. Tickell S. The Antibiotic Innovation Study: Expert Voices on a Critical need. REACT, Action on Antibiotic Resistance 2005. http://soapimg.icecube.snowfall.se/stopresistance/executive%20summary%20antibiotic%20innovation%20study.pdf (14 February 2007, date last accessed).
17. Finch R, Hunter PA. Antibiotic resistance-action to promote new technologies: report of an EU intergovernmental conference held in Birmingham, UK, 12-13 December 2005. J Antimicrob Chemother 2006; 58 Suppl S1: i3-22.